# EDGAR Filing Document

**Accession Number:** 0001877184
**File Stem:** 0001193125-25-303153
**Filing Date:** 2025-12
**Character Count:** 3591
**Document Hash:** a97fefc45e51119e5cf24a2f298564fd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-303153.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001193125-25-303153

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251201

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KESTRA MEDICAL TECHNOLOGIES, LTD.
- **CENTRAL INDEX KEY:** 0001877184
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3933 LAKE WASHINGTON BLVD NE
- **STREET 2:** SUITE 200
- **CITY:** KIRKLAND
- **STATE:** WA
- **ZIP:** 98033
- **BUSINESS PHONE:** (425) 279-8002

**MAIL ADDRESS:**
- **STREET 1:** 3933 LAKE WASHINGTON BLVD NE
- **STREET 2:** SUITE 200
- **CITY:** KIRKLAND
- **STATE:** WA
- **ZIP:** 98033

December 1, 2025

***VIA EDGAR***

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street N.E.

Washington, D.C. 20549-6010

Attn: Juan Grana

Margaret Sawicki

Al Pavot

Terence O'Brien

---

| | |
|:---|:---|
| **Re:** | **Kestra Medical Technologies, Ltd.**  |

---

**Registration Statement on Form S-1 (File No. 333-291854)** 

**Request for Acceleration of Effective Date** 

Ladies and Gentlemen:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the "<u>Act</u>"), we hereby join in the request of Kestra Medical Technologies, Ltd. (the "<u>Registrant</u>") that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Washington, D.C. time, on December 2, 2025, or as soon as thereafter practicable, or at such later time as the Registrant or its outside counsel, Kirkland & Ellis LLP, may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission.

Please be advised that we have not distributed any copies of the Preliminary Prospectus dated December 1, 2025 (the "<u>Preliminary Prospectus</u>") through the date hereof, but pursuant to Rule 460 under the Act there will be distributed to underwriters, dealers, institutions and others who are reasonably anticipated to be invited to participate in the distribution of the shares as many copies of the Preliminary Prospectus as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

Very truly yours,

BOFA SECURITIES, INC.

PIPER SANDLER & CO.

J.P. MORGAN SECURITIES LLC

GOLDMAN SACHS & CO. LLC

As Representatives of the several underwriters

[*Signature Pages Follow*]

------

---

| | |
|:---|:---|
| BOFA SECURITIES, INC. | BOFA SECURITIES, INC. |
| By: | /s/ Milton Hsu |
|  | Name: Milton Hsu |
|  | Title: Managing Director |
| PIPER SANDLER & CO. | PIPER SANDLER & CO. |
| By: | /s/ Neil Riley |
|  | Name: Neil Riley |
|  | Title: Managing Director |
| J.P. MORGAN SECURITIES LLC | J.P. MORGAN SECURITIES LLC |
| By: | /s/ Benjamin Burdett |
|  | Name: Benjamin Burdett |
|  | Title: Managing Director, Head of Healthcare Equity Capital Markets |
| GOLDMAN SACHS & CO. LLC | GOLDMAN SACHS & CO. LLC |
| By: | /s/ Lyla Bibi Maduri |
|  | Name: Lyla Bibi Maduri |
|  | Title: Managing Director |

---

As representatives of the several underwriters

cc: Ilir Mujalovic, *Allen Overy Shearman Sterling US LLP*

[*Signature Page to Acceleration Request Letter*]